Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

Deutsche Bank downgraded Informatica (INFA) to Hold from Buy with a $21 price target The firm cites the company’s “disappointing” Q4 results ...

Deutsche Bank, Germany’s largest financial institution, has partnered with Swiss crypto company Taurus and launched a ...

(Reuters) - CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that ...

Fintel reports that on February 11, 2025, Deutsche Bank initiated coverage of Biohaven (NYSE:BHVN) with a Buy recommendation.

M&A markets don't like volatility and unpredictability, and what we've seen in the past few weeks is the opposite of that,” ...

DeepSeek has enabled investors to see the potential of Chinese technology stocks. Since February, several foreign-funded ...

Amazon's Q4 earnings beat analyst expectations, but AMZN stock sunk over 5% after hours. The call's discussion focused on AI ...

FRANKFURT, Germany (AP) — FRANKFURT, Germany (AP) — Deutsche Bank AG (DB) on Thursday reported net income of $324.3 million in its fourth quarter. The bank, based in Frankfurt, Germany, said it had ...

I previously covered Deutsche Bank in October 2024 with a Buy rating, arguing analysts remained too pessimistic about the company's 2025-2026 profitability outlook. Deutsche Bank recently released ...

Deutsche Bank has structurally turned the tide on its profitbility outlook after multiple failed restructuring attempts. In its latest and successful effort, the bank has shed its global equities ...